» Articles » PMID: 34268484

The MicroRNA MiR-21 Conditions the Brain to Protect Against Ischemic and Traumatic Injuries

Overview
Journal Cond Med
Date 2021 Jul 16
PMID 34268484
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic and traumatic injuries to CNS remain leading causes of death and disability worldwide, despite decades of research into risk factors, therapies, and preventative measures. Recent studies showed that CNS injuries significantly alter the cerebral microRNAome that impact the secondary brain damage as well as plasticity and recovery. Many microRNA based therapies are currently in various clinical trials for different pathologic conditions indicating their therapeutic potential. In the present review, we discuss the role of miR-21 in acute CNS injuries which is currently thought to be a potent neuroprotective microRNA. We emphasize on the potential of miR-21 in promoting cell and tissue survival and preventing inflammation and apoptosis. We also discussed the role of miR-21 in conditioning the brain to promote ischemic tolerance. Finally, we discussed some of the challenges and difficulties to develop miR-21 as a neuroprotective therapy in humans.

Citing Articles

The Therapeutic Potential of MicroRNA-21 in the Treatment of Spinal Cord Injury.

Hasan A, Ardizzone A, Giosa D, Scuderi S, Calcaterra E, Esposito E Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996791 PMC: 11854632. DOI: 10.3390/cimb47020070.


Post-stroke cognitive impairment: exploring molecular mechanisms and omics biomarkers for early identification and intervention.

Lu Q, Yu A, Pu J, Chen D, Zhong Y, Bai D Front Mol Neurosci. 2024; 17:1375973.

PMID: 38845616 PMC: 11153683. DOI: 10.3389/fnmol.2024.1375973.


Deciphering the Role of microRNAs: Unveiling Clinical Biomarkers and Therapeutic Avenues in Atrial Fibrillation and Associated Stroke-A Systematic Review.

Boxhammer E, Dienhart C, Rezar R, Hoppe U, Lichtenauer M Int J Mol Sci. 2024; 25(10.

PMID: 38791605 PMC: 11122365. DOI: 10.3390/ijms25105568.


Therapeutic Potential of Intravenous miR-21 Mimic after Stroke Following STAIR Criteria.

Chelluboina B, Jeong S, Davis C, Mehta S, Vemuganti R Transl Stroke Res. 2023; .

PMID: 38129636 PMC: 11365116. DOI: 10.1007/s12975-023-01223-8.


Commentary: Can astrocytic mitochondria therapy be used as antioxidant conditioning to protect neurons?.

Hayakawa K Cond Med. 2023; 5(6):192-195.

PMID: 38037662 PMC: 10688760.


References
1.
Stetler R, Leak R, Gan Y, Li P, Zhang F, Hu X . Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. Prog Neurobiol. 2014; 114:58-83. PMC: 3937258. DOI: 10.1016/j.pneurobio.2013.11.005. View

2.
Hu J, Huang J, Zeng L, Wang G, Cao M, Lu H . Anti-apoptotic effect of microRNA-21 after contusion spinal cord injury in rats. J Neurotrauma. 2013; 30(15):1349-60. PMC: 3727528. DOI: 10.1089/neu.2012.2748. View

3.
Yin K, Deng Z, Huang H, Hamblin M, Xie C, Zhang J . miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 2010; 38(1):17-26. PMC: 2837803. DOI: 10.1016/j.nbd.2009.12.021. View

4.
Ziu M, Fletcher L, Rana S, Jimenez D, Digicaylioglu M . Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS One. 2011; 6(2):e14724. PMC: 3044134. DOI: 10.1371/journal.pone.0014724. View

5.
Li Z, Jiang H, Xie W, Zhang Z, Smrcka A, Wu D . Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science. 2000; 287(5455):1046-9. DOI: 10.1126/science.287.5455.1046. View